Bracco Targets Cell Therapy Manufacturing with Bead-Free Microbubble Cell Processing
February 13, 2026
Bead-free microbubble approach aims to simplify cell selection and activation for scalable cell therapy manufacturing
2 min read
False
Advertisement
Cell & Gene
Training the Medicine Makers the UK Can’t Afford to Lose
February 12, 2026
Why immersive training could be critical to closing the UK’s medicines manufacturing skills gap
4 min read
Overcoming the Challenges of AI Antibody Analysis
By Ben Holland
February 4, 2026
Cracking the molecular code
5 min read
Cellares and City of Hope to Automate Manufacturing of Solid Tumor CAR T Cell Therapy
January 27, 2026
Collaboration addresses solid tumor manufacturing bottlenecks and accelerates advancement toward clinical trials
2 min read
UK Increase in Advanced Therapy Clinical Trials
January 26, 2026
Number of early-stage trials remains high, according to CGT Catapult data
1 min read
Discussing the Big Ideas in Medicine Manufacturing: Part II
January 19, 2026
More experts share their thoughts on the next “big ideas” that they think will shape the near future of therapy developments.
10 min read
Manufacturability and the Winners in Advanced Therapies
By Stephanie Vine
January 13, 2026
Are developers still underestimating the engineering sophistication required to scale advanced therapies in the real world? Alan Boyd discusses.
7 min read
Promising Data For Off-the-Shelf Gene-edited Cell Therapy
December 17, 2025
New clinical results outline patient responses to a donor-derived, gene-edited cell therapy in relapsed and refractory T-cell leukemia
2 min read
Bridging the Digital Divide: How Collaboration and Standardization Are Shaping the Future of Biotech
By Heather Purvis
December 17, 2025
The promise of cell and gene therapy is boundless, but data silos are holding it back. Standardization, interoperability, and collaboration can move data as freely as science itself.
5 min read
Outsmarting Cancer: The “Trojan Horse” of Gene Therapy
By Stephanie Vine
December 11, 2025
Borrowing strategy from ancient Greece, Trogenix hides its therapeutic warriors inside tumor cells. CEO Ken Macnamara discusses how.
5 min read
